DOK1 is considered to have antitumor roles in several cancers, such as chronic lymphocytic leukemia (CLL) 9, chronic myelogenous leukemia (CML) 8, histiocytic sarcoma 10, lung cancer 14, and epithelial ovarian cancer 15. This evidence concerns the gene DOK1 and B-cell chronic lymphocytic leukemia.